Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
Operating Expenses | 1,784 | 2,292 | 3,476 | 2,394 | 2,471 |
Operating Income | -1,784 | -2,292 | -3,476 | -2,394 | -2,471 |
Interest Expense | 0 | 0 | 0 | 5 | 0 |
Other Income | 185 | 124 | 137 | 69 | 22 |
Pre-tax Income | -1,599 | -2,168 | -3,339 | -2,330 | -2,449 |
Net Income Continuous | -1,599 | -2,168 | -3,339 | -2,330 | -2,449 |
Net Income | $-1,599 | $-2,168 | $-3,339 | $-2,330 | $-2,449 |
EPS Basic Total Ops | -0.56 | -0.76 | -1.17 | -0.82 | -0.87 |
EPS Basic Continuous Ops | -0.56 | -0.76 | -1.18 | -0.82 | -0.87 |
EPS Diluted Total Ops | -0.56 | -0.76 | -1.17 | -0.82 | -0.87 |
EPS Diluted Continuous Ops | -0.56 | -0.76 | -1.18 | -0.82 | -0.87 |
EPS Diluted Before Non-Recurring Items | -0.56 | -0.76 | -1.18 | -0.82 | N/A |
EBITDA(a) | $-1,784 | $-2,292 | $-3,476 | $-2,394 | $-2,471 |